JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405089200 on September 27, 2004

J. Biol. Chem., Vol. 279, Issue 49, 50904-50914, December 3, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
279/49/50904    most recent
M405089200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granier, S.
Right arrow Articles by Mendre, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granier, S.
Right arrow Articles by Mendre, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Cyclic Peptide Mimicking the Third Intracellular Loop of the V2 Vasopressin Receptor Inhibits Signaling through Its Interaction with Receptor Dimer and G Protein*{boxs}

Sébastien Granier{ddagger}, Sonia Terrillon§, Robert Pascal||, Hélène Déméné**, Michel Bouvier§{ddagger}{ddagger}, Gilles Guillon{ddagger}, and Christiane Mendre{ddagger}§§

From the {ddagger}Unité INSERM U469, CCIPE, 141 rue de la Cardonille, 34094 Montpellier Cedex, France, §Département Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada, ||UMR 5073, Université Montpellier 2, CC017, Place E. Bataillon, 34095 Montpellier Cedex, and **UMR 5048 CNRS-UM1/UMR 554 INSERM-UM1, Centre de Biochimie Structurale, 29 rue de Navacelles, 34060 Montpellier Cedex, France

In this study, we investigated the mechanism by which a peptide mimicking the third cytoplasmic loop of the vasopressin V2 receptor inhibits signaling. This loop was synthesized as a cyclic peptide (i3 cyc) that adopted defined secondary structure in solution. We found that i3 cyc inhibited the adenylyl cyclase activity induced by vasopressin or a nonhydrolyzable analog of GTP, guanosine 5'-O-(3-thio)triphosphate. This peptide also affected the specific binding of [3H]AVP by converting vasopressin binding sites from a high to a low affinity state without any effect on the global maximal binding capacity. The inhibitory actions of i3 cyc could also be observed in the presence of maximally uncoupling concentration of guanosine 5'-O-(3-thio)triphosphate, indicating a direct effect on the receptor itself and not exclusively on the interaction between the Gs protein and the V2 receptor (V2-R). Bioluminescence resonance energy-transfer experiments confirmed this assumption, because i3 cyc induced a significant inhibition of the bioluminescence resonance energy-transfer signal between the Renilla reniformis luciferase and the enhanced yellow fluorescent protein fused V2-R. This suggests that the proper arrangement of the dimer could be an important prerequisite for triggering Gs protein activation. In addition to its effect on the receptor itself, the peptide exerted some of its actions at the G protein level, because it could also inhibit guanosine 5'-O-(3-thio)triphosphate-stimulated AC activity. Taken together, the data demonstrate that a peptide mimicking V2-R third intracellular loop affects both the dimeric structural organization of the receptor and has direct inhibitory action on Gs.


Received for publication, May 7, 2004 , and in revised form, September 9, 2004.

* This work was supported by the PCV00–86 grant from the "Programme CNRS Physique Chimie du Vivant" and a grant from the Canadian Institute for Health Research, the Kidney Foundation of Canada, and travel grant from the Fonds de la Recherche en Santé du Québec (to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. S1–S3.

Supported by a studentship from the Fondation pour la Recherche Médicale.

{ddagger}{ddagger} Holder of the Hans Selye Chair in Molecular and Cell Biology as well as a Canada Research Chair in Signal Transduction and Molecular Pharmacology.

§§ To whom correspondence should be addressed. Tel.: 33-4-67-14-29-84; Fax: 33-4-67-54-24-32; E-mail: christiane.mendre{at}ccipe.cnrs.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Wu, R. Macion-Dazard, S. Nithianantham, Z. Xu, S. M. Hanson, S. A. Vishnivetskiy, V. V. Gurevich, M. Thibonnier, and M. Shoham
Soluble Mimics of the Cytoplasmic Face of the Human V1-Vascular Vasopressin Receptor Bind Arrestin2 and Calmodulin
Mol. Pharmacol., July 1, 2006; 70(1): 249 - 258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.